vVARDIS Holding AG has taken a major step in its growth strategy by filing for an initial public offering (IPO) with the Securities and Exchange Commission on October 9, 2026. This filing indicates the company's intent to expand its footprint in the surgical and medical instruments industry, a sector that is witnessing increased competition and innovation.
The filing states that vVARDIS is offering Class A ordinary shares with a par value of CHF 0.006. The company will not receive any proceeds from shares sold by selling shareholders, but it aims to raise capital through the issuance of new shares. The underwriters will also have the option to purchase additional shares to cover over-allotments, if necessary.
vVARDIS Holding AG, incorporated in Switzerland, operates under the Standard Industrial Classification (SIC) code 3841, which pertains to Surgical & Medical Instruments & Apparatus. The company is co-founded by Haley Abivardi and Goly Abivardi, who currently serve as Co-Chief Executive Officers. The registration statement filed with the SEC is identified under accession number 0001140361-26-039234.
According to the filing, the company plans to list its Class A ordinary shares on the New York Stock Exchange under the ticker symbol “VVVV.” The expected initial public offering price is yet to be determined, but the company has indicated that it will be between a specified range.
The filing highlights the structure of the company's share capital, which will include both Class A ordinary shares and Class B voting rights shares. The Class B shares will be held exclusively by the founders and will carry ten times the voting power of Class A shares. This structure is designed to maintain control within the founding team while allowing for public investment.
As an emerging growth company, vVARDIS has opted to take advantage of certain reduced public company reporting requirements, which may provide it with more flexibility as it navigates the public market.
The surgical and medical instruments industry is becoming increasingly competitive, and vVARDIS's entry into the public market could signal a shift in market dynamics. Other companies in this sector may need to reassess their strategies in light of vVARDIS's IPO plans.
What's next for vVARDIS Holding AG is the completion of the IPO process, which will depend on the effectiveness of the registration statement filed with the SEC. The company has not specified a timeline for when it expects the IPO to be finalized, but it aims to commence selling its shares as soon as practicable after the registration statement becomes effective.